During the recent years, data regarding osteoporosis has accumulated and indicates that osteoporotic fractures in Scandinavia still increase. At the same time diagnostics and treatments have been improved. However, only a minority of patients with fractures and osteoporosis become identified. Surgeons and hospitals treating fractures should find means to detect patients who suffer from fractures due to osteoporosis, and establish programs for further evaluation and adequate treatment.
References
1.
CummingsSRNevittMCBrownerWSStoneKFoxKMEnsrudKERisk factors for hip fracture in white women. Study of osteoporotic fractures research group. N Engl J Med1995; 332: 767–773.
2.
HuopioJKrögerHHonkanenRSaarikoskiSAlhavaERisk factors for perimenopausal fractures. A prospective population based study. Osteoporosis Int2000; 11: 219–227.
3.
HonkanenRTuppurainenMKrögerHAlhavaESaarikoskiSRelationships between risk factors and fractures differ by type of fractures — A population-based study of 12 192 perimenopausal women. Osteoporosis Int1998;8:25–31.
4.
BlackDArdenNPalermoLPearsonJCummingsSRPrevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res1999;14:821–828.
5.
MallminHLjunghallSPerssonINaessenTFracture of the distal forearm as a forecaster of subsequent hip fracture: A population-based cohort study with 24 years of follow-up. Calcif Tissue Int1993;52:269–272.
6.
RouxCEriksenEBrownJOne-in-five risk of new vertebral fracture within 1 year of an incident fracture. J Bone Miner Res2000: 15 (suppl 1):S223.
7.
KrögerHReeveJDiagnosis of osteoporosis in clinical practice. Ann Med1998;30:278–287.
8.
KrögerHHonkanenRIdentifying the patient at risk of osteoporotic fracture. Kirjassa: ObrantKManagement of Fracture in Severely Osteoporotic Bone: Orthopedic and Pharmacological Strategies, 85–98. Springer —Verlag London Ltd2000.
9.
BlackDMCummingsSRKarpfDBCauleyJAThompsonDENevittMCBauerDCRandomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet1996; 348: 1535–4151.
10.
CummingsSRBlackDMThompsonDEApplegateWBBarrett-ConnorEMuslinerTAEffect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial. JAMA1998;280:2077–2082.
11.
McClungMRGeusensPMillerPDZippelHBensenWGRouxCEffect of risedronate on the risk of hip fracture in elderly women. N Engl J Med2001;344:333–340.
12.
EttingerBBlackDMMitlakBHKnickerbockerRKNickelsenTGenantHKReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA1999; 282: 637–645.
13.
ChesnutCHSilvermanSAndrianoKGenantHGimonaAHarrisSKielDDe BoffMA randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med2000; 109: 267–276.
14.
ChapuyMCArlotMEDuboeufFBrunJCrouzetBArnaudSVitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med1992;327:1637–1642.
15.
KomulainenMKrögerHTuppurainenMTHeikkinenA-MAlhavaEHonkanenRSaarikoskiSHRT and Vit D in prevention of non-vertebral fractures in postmenopausal women — A 5 year randomized trial. Maturitas1998;31:45–54.
16.
CuddihyMMPGabrielSECrowsonCAtkinsonEJTabiniCO'FallonWMMeltonLJIIIOsteoporosis management in postmenopausal women after low impact distal forearm fracture: A missed opportunity. J Bone Miner Res2000; 15:S560.
17.
BroySBBohrenAHarringtonTLicataAShewmanDAre physicians treating osteoporosis after hip fracture. J Bone Miner Res2000; 15:S141.
18.
McLellanARFraserMBrownJO'BrienPJThe osteoporosis-orthopaedic liaison nurse: A model for effecting secondary prevention of osteoporotic fractures in an orthopaedic accident ad accident and emergency setting. J Bone Miner Res2000;15:S439.
